• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤回:高血压与高密度脂蛋白胆固醇:一篇叙述性综述。

WITHDRAWN: Hypertension and High-Density Lipoprotein Cholesterol: A Narrative Review.

作者信息

Liu Rufei, Cheng Wenli

机构信息

Hypertension Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

出版信息

Curr Hypertens Rev. 2025 Mar 21. doi: 10.2174/0115734021345634241115115253.

DOI:10.2174/0115734021345634241115115253
PMID:39686636
Abstract

UNLABELLED

Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php

BENTHAM SCIENCE DISCLAIMER

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

摘要

未标注

由于作者未回应编辑满足编辑要求的请求,因此,该文章已被撤回。本特姆科学出版社就此事可能给期刊读者带来的不便深表歉意。关于文章撤回的本特姆科学出版社编辑政策可在https://benthamscience.com/editorial-policies-main.php查询。

本特姆科学出版社免责声明

提交至本期刊的稿件未在其他地方发表且不会同时提交至其他地方发表或在其他地方发表,这是发表的条件。此外,任何已在其他地方发表的数据、插图、结构或表格必须报告,并必须获得复制的版权许可。严禁抄袭,提交文章以供发表即表示作者同意,如果发现抄袭或虚假信息,出版方有权对作者采取适当行动。提交稿件即表示作者同意,如果文章被接受发表,其文章版权将转让给出版方。

相似文献

1
WITHDRAWN: Hypertension and High-Density Lipoprotein Cholesterol: A Narrative Review.撤回:高血压与高密度脂蛋白胆固醇:一篇叙述性综述。
Curr Hypertens Rev. 2025 Mar 21. doi: 10.2174/0115734021345634241115115253.
2
WITHDRAWN: Identifying 2PHDO as a SOCE Inhibitor from Chinese Herbal Extracts.撤回:从中药提取物中鉴定2-苯基-1,4-二氢吡啶并[3,2-c]菲啶-1,3(2H)-二酮作为一种钙库操纵性钙内流抑制剂。
Curr Pharm Biotechnol. 2023 Sep 28. doi: 10.2174/1389201024666230614113457.
3
WITHDRAWN: Role of Biomarkers for Diagnosis and Prediction in Type 1 Diabetes: An Overview.撤回:生物标志物在1型糖尿病诊断和预测中的作用:综述
Curr Drug Discov Technol. 2025 Mar 28. doi: 10.2174/0115701638319534250314075737.
4
WITHDRAWN: Green Synthesis and Evaluation of the Biological Activity of New Dihydropyridine Derivatives.撤回:新型二氢吡啶衍生物的绿色合成及其生物活性评估
Comb Chem High Throughput Screen. 2024 Jun 14. doi: 10.2174/0113862073298086240529073719.
5
WITHDRAWN: Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of Weight Loss; A Systematic Review.撤回:双重GIP和GLP-1受体激动剂替尔泊肽在体重减轻管理中的作用;一项系统评价
Curr Drug Saf. 2024 Oct 31. doi: 10.2174/0115748863330434241015125302.
6
WITHDRAWN: Comparative Experimental Study of using Tramadol and Nefopam in Pain Management.撤回:曲马多与奈福泮用于疼痛管理的比较实验研究。
Comb Chem High Throughput Screen. 2024 Aug 22. doi: 10.2174/0113862073252534231122073045.
7
Withdrawn: Camel FGF21 Protein Enhances FGF21 Signaling and its Targeted Compounds Screening.撤回:骆驼FGF21蛋白增强FGF21信号传导及其靶向化合物筛选
Curr Pharm Des. 2024 Sep 30. doi: 10.2174/0113816128332755240912041051.
8
WITHDRAWN: Pyridazine Derivatives: Molecular Docking ADMET Prediction and Synthesis for Antihypertensive Activity.撤回:哒嗪衍生物:用于抗高血压活性的分子对接、ADMET预测及合成
Cardiovasc Hematol Agents Med Chem. 2024 Aug 19. doi: 10.2174/0118715257316272240807075752.
9
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.撤回:稳定的胃十五肽BPC 157作为大鼠严重电解质紊乱的治疗方法。
Curr Neuropharmacol. 2025 Jan 24. doi: 10.2174/011570159X349612241205065330.
10
Withdrawn: Fumarate-1 Mediates the Regulation of Mitochondrial Homeostasis by PGC-1α to Promote Cell Pyroptosis and Inhibit the Thyroid Cancer.撤回:富马酸酯-1通过PGC-1α介导线粒体稳态调节以促进细胞焦亡并抑制甲状腺癌。
Recent Pat Anticancer Drug Discov. 2024 Jul 11. doi: 10.2174/0115748928282936240530105434.